Literature DB >> 16899836

Nonacid reflux in patients with chronic cough on acid-suppressive therapy.

Radu Tutuian1, Inder Mainie, Amit Agrawal, David Adams, Donald O Castell.   

Abstract

BACKGROUND: It is generally accepted that extraesophageal gastroesophageal reflux disease (GERD) symptoms and their persistence despite acid-suppressive therapy are poor prognostic factors for antireflux surgery. Recent studies indicating that cough can be temporally associated with reflux episodes of pH 4 to 7 (ie, nonacid reflux) reinvigorates the need for a more careful workup in patients with cough suspected to be due to GERD. AIM: To evaluate the frequency of chronic cough associated with nonacid reflux and the response of these patients to laparoscopic Nissen fundoplication.
METHODS: We retrospectively reviewed data from patients with persistent cough despite twice-daily proton pump inhibitor (PPI) with or without the use of nighttime regimens of histamine-2 receptor antagonist (H2RA), who had undergone combined multichannel intraluminal impedance and pH monitoring. The association of cough and reflux was evaluated by calculating the symptom index (SI) [positive if > or = 50%]. A subset of patients with positive SI values for impedance-detected reflux with therapy was referred for laparoscopic Nissen fundoplication.
RESULTS: Of 50 patients (38 female patients; mean age, 43 years; age range, 6 months to 84 years) who were monitored while receiving therapy, 13 patients (26%) had a positive SI for cough. The SI-positive group had a lower percentage of female patients and patients of younger age compared to the SI-negative group. Laparoscopic Nissen fundoplication was performed in six SI-positive patients who became asymptomatic and stopped receiving acid-suppressive therapy during follow-up evaluations (median time, 17 months; range, 12 to 27 months).
CONCLUSION: Impedance pH monitoring should be performed while receiving therapy in patients with persistent symptoms who are receiving PPI therapy. A positive SI for nonacid reflux may be helpful in selecting patients who will benefit from antireflux surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899836     DOI: 10.1378/chest.130.2.386

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  45 in total

Review 1.  New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance.

Authors:  Jason A Wilson; Marcelo F Vela
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

3.  Clinical outcomes of gastroesophageal reflux disease-related chronic cough following antireflux fundoplication.

Authors:  Tamara Díaz Vico; Enrique F Elli
Journal:  Esophagus       Date:  2019-10-15       Impact factor: 4.230

4.  Reflux Finding Score (RFS) a Quantitative Guide for Diagnosis and Treatment of Laryngopharyngeal Reflux.

Authors:  Y K Kirti
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-10

5.  Laryngopharyngeal Reflux: Weak Acid and Weaker Correlations.

Authors:  Steven R DeMeester
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

6.  Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children.

Authors:  Helena Turk; Bruno Hauser; Jernej Brecelj; Yvan Vandenplas; Rok Orel
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

Review 7.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

Review 8.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

9.  Regurgitation in healthy and non healthy infants.

Authors:  Flavia Indrio; Giuseppe Riezzo; Francesco Raimondi; Luciano Cavallo; Ruggiero Francavilla
Journal:  Ital J Pediatr       Date:  2009-12-09       Impact factor: 2.638

10.  Pulmonary manifestations of gastroesophageal reflux disease.

Authors:  Gajanan S Gaude
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.